Cargando…

Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?

Detalles Bibliográficos
Autor principal: Mauvais-Jarvis, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319722/
https://www.ncbi.nlm.nih.gov/pubmed/28223340
http://dx.doi.org/10.2337/dbi16-0063
_version_ 1782509418743595008
author Mauvais-Jarvis, Franck
author_facet Mauvais-Jarvis, Franck
author_sort Mauvais-Jarvis, Franck
collection PubMed
description
format Online
Article
Text
id pubmed-5319722
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-53197222018-03-01 Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women? Mauvais-Jarvis, Franck Diabetes Commentaries American Diabetes Association 2017-03 2017-02-14 /pmc/articles/PMC5319722/ /pubmed/28223340 http://dx.doi.org/10.2337/dbi16-0063 Text en © 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle Commentaries
Mauvais-Jarvis, Franck
Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
title Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
title_full Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
title_fullStr Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
title_full_unstemmed Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
title_short Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
title_sort is estradiol a biomarker of type 2 diabetes risk in postmenopausal women?
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319722/
https://www.ncbi.nlm.nih.gov/pubmed/28223340
http://dx.doi.org/10.2337/dbi16-0063
work_keys_str_mv AT mauvaisjarvisfranck isestradiolabiomarkeroftype2diabetesriskinpostmenopausalwomen